Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience cash
Cash and short-term investments held at the end of each period.
Dare Bioscience's cash was $12.62M at Jun 30, 2026. For fiscal 2025 it was $24.71M, up 54.5% from the year before. Over ten years it grew 60.4% a year on average. The highest annual figure on record is $51.67M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.71M | +54.5% |
| FY2024 | Dec 31, 2024 | $16.00M | +48.0% |
| FY2023 | Dec 31, 2023 | $10.81M | -68.8% |
| FY2022 | Dec 31, 2022 | $34.67M | -32.9% |
| FY2021 | Dec 31, 2021 | $51.67M | +1006.6% |
| FY2020 | Dec 31, 2020 | $4.67M | -2.3% |
| FY2019 | Dec 31, 2019 | $4.78M | -29.8% |
| FY2018 | Dec 31, 2018 | $6.81M | -10.0% |
| FY2017 | Dec 31, 2017 | $7.56M | +16845.0% |
| FY2016 | Dec 31, 2016 | $44.61K | -79.7% |
| FY2015 | Dec 31, 2015 | $219.41K | -99.6% |
| FY2014 | Dec 31, 2014 | $51.17M | +832.5% |
| FY2013 | Dec 31, 2013 | $5.49M | -67.2% |
| FY2012 | Dec 31, 2012 | $16.71M | +8.9% |
| FY2011 | Dec 31, 2011 | $15.35M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.62M | +150.6% |
| Q1 FY2026 | Mar 31, 2026 | $18.52M | +79.3% |
| Q4 FY2025 | Dec 31, 2025 | $24.71M | +54.5% |
| Q3 FY2025 | Sep 30, 2025 | $23.08M | +105.4% |
| Q2 FY2025 | Jun 30, 2025 | $5.04M | -69.3% |
| Q1 FY2025 | Mar 31, 2025 | $10.33M | +184.5% |
| Q4 FY2024 | Dec 31, 2024 | $16.00M | +48.0% |
| Q3 FY2024 | Sep 30, 2024 | $11.23M | -19.2% |
| Q2 FY2024 | Jun 30, 2024 | $16.41M | +23.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.63M | -81.6% |
| Q4 FY2023 | Dec 31, 2023 | $10.81M | -68.8% |
| Q3 FY2023 | Sep 30, 2023 | $13.89M | -65.6% |
| Q2 FY2023 | Jun 30, 2023 | $13.33M | -58.4% |
| Q1 FY2023 | Mar 31, 2023 | $19.74M | -49.8% |
| Q4 FY2022 | Dec 31, 2022 | $34.67M | -32.9% |
| Q3 FY2022 | Sep 30, 2022 | $40.39M | -11.4% |
| Q2 FY2022 | Jun 30, 2022 | $32.07M | +252.0% |
| Q1 FY2022 | Mar 31, 2022 | $39.32M | +413.3% |
| Q4 FY2021 | Dec 31, 2021 | $51.67M | +1006.6% |
| Q3 FY2021 | Sep 30, 2021 | $45.57M | +745.6% |
| Q2 FY2021 | Jun 30, 2021 | $9.11M | +70.4% |
| Q1 FY2021 | Mar 31, 2021 | $7.66M | +51.8% |
| Q4 FY2020 | Dec 31, 2020 | $4.67M | -2.3% |
| Q3 FY2020 | Sep 30, 2020 | $5.39M | +121.3% |
| Q2 FY2020 | Jun 30, 2020 | $5.35M | -5.0% |
| Q1 FY2020 | Mar 31, 2020 | $5.05M | +44.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.78M | -29.8% |
| Q3 FY2019 | Sep 30, 2019 | $2.44M | -74.5% |
| Q2 FY2019 | Jun 30, 2019 | $5.63M | -54.8% |
| Q1 FY2019 | Mar 31, 2019 | $3.51M | -77.6% |
| Q4 FY2018 | Dec 31, 2018 | $6.81M | -10.0% |
| Q3 FY2018 | Sep 30, 2018 | $9.54M | +11.8% |
| Q2 FY2018 | Jun 30, 2018 | $12.45M | +31486.2% |
| Q1 FY2018 | Mar 31, 2018 | $15.63M | +16519.0% |
| Q4 FY2017 | Dec 31, 2017 | $7.56M | +16845.0% |
| Q3 FY2017 | Sep 30, 2017 | $8.53M | +60537.1% |
| Q2 FY2017 | Jun 30, 2017 | $39.41K | – |
| Q1 FY2017 | Mar 31, 2017 | $94.02K | – |
| Q4 FY2016 | Dec 31, 2016 | $44.61K | – |
| Q3 FY2016 | Sep 30, 2016 | $14.07K | – |
See a number that looks wrong?